Cargando…
Metabolic Effects of Selective Deletion of Group VIA Phospholipase A(2) from Macrophages or Pancreatic Islet Beta-Cells
To examine the role of group VIA phospholipase A(2) (iPLA(2)β) in specific cell lineages in insulin secretion and insulin action, we prepared mice with a selective iPLA(2)β deficiency in cells of myelomonocytic lineage, including macrophages (MØ-iPLA(2)β-KO), or in insulin-secreting β-cells (β-Cell-...
Autores principales: | Turk, John, Song, Haowei, Wohltmann, Mary, Frankfater, Cheryl, Lei, Xiaoyong, Ramanadham, Sasanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602969/ https://www.ncbi.nlm.nih.gov/pubmed/33080873 http://dx.doi.org/10.3390/biom10101455 |
Ejemplares similares
-
Genetic modulation of islet β-cell iPLA(2)β expression provides evidence for its impact on β-cell apoptosis and autophagy
por: Lei, Xiaoyong, et al.
Publicado: (2013) -
Group VIB Phospholipase A(2) Promotes Proliferation of INS-1 Insulinoma Cells and Attenuates Lipid Peroxidation and Apoptosis Induced by Inflammatory Cytokines and Oxidant Agents
por: Bao, Shunzhong, et al.
Publicado: (2012) -
Inhibition of Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice
por: Bone, Robert N., et al.
Publicado: (2015) -
The Impact of the Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) on Immune Cells
por: White, Tayleur D., et al.
Publicado: (2021) -
Characterization of FKGK18 as Inhibitor of Group VIA Ca(2+)-Independent Phospholipase A(2) (iPLA(2)β): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes
por: Ali, Tomader, et al.
Publicado: (2013)